Administration of the EGLN inhibitor FG-4592 prior to ablative radiotherapy provided protection against fatal gastrointestinal bleeding and improved survival in a mouse model of unresectable pancreatic cancer.
from EurekAlert! - Breaking News http://bit.ly/2vuQHOR
via IFTTT
Tuesday, April 30, 2019
EGLN inhibitor protects normal tissue and enables RT in mouse model of pancreatic cancer
About Admin -
Author Description here.. Nulla sagittis convallis. Curabitur consequat. Quisque metus enim, venenatis fermentum, mollis in, porta et, nibh. Duis vulputate elit in elit. Mauris dictum libero id justo.